BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2557568)

  • 21. Alpha 1- and beta-adrenergic and muscarinic cholinergic receptors in guinea-pig nasal mucosa.
    Ishibe T; Kuno T; Tanaka C
    Eur J Pharmacol; 1984 Oct; 106(1):107-12. PubMed ID: 6099264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
    Taniguchi T; Tsukahara T; Fujiwara M
    Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition by local anesthetics, phentolamine and propranolol of [3H]quinuclydinyl benzylate binding to central muscarinic receptors.
    Aguilar JS; Criado M; De Robertis E
    Eur J Pharmacol; 1980 Dec; 68(3):317-26. PubMed ID: 7202495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [3H]Quinuclidinyl benzilate binding to muscarinic receptors and [3H]WB-4101 binding to alpha-adrenergic receptors in rabbit iris. Comparison of results in slices and microsomal fractions.
    Taft WC; Abdel-Latif AA; Akhtar RA
    Biochem Pharmacol; 1980 Oct; 29(20):2713-20. PubMed ID: 6108112
    [No Abstract]   [Full Text] [Related]  

  • 25. Muscarinic receptors on intact, cultured neurons. Characterization by [3H]quinuclidinylbenzilate binding.
    Frick W; Hefti F; Citherlet K; Dravid A; Gmelin G
    Neurosci Lett; 1983 Sep; 40(1):45-50. PubMed ID: 6633966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of high affinity [3H]pirenzepine and (-)-[3H] quinuclidinyl benzilate binding to muscarinic cholinergic receptors in rabbit peripheral lung.
    Bloom JW; Halonen M; Lawrence LJ; Rould E; Seaver NA; Yamamura HI
    J Pharmacol Exp Ther; 1987 Jan; 240(1):51-8. PubMed ID: 3806397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo competition studies with analogues of 3-quinuclidinyl benzilate.
    Eckelman WC; Grissom M; Conklin J; Rzeszotarski WJ; Gibson RE; Francis BE; Jagoda EM; Eng R; Reba RC
    J Pharm Sci; 1984 Apr; 73(4):529-34. PubMed ID: 6327965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of 3H-quinuclidinyl benzylate binding to cardiac muscarinic receptor by long chain fatty acids can be attenuated by ligand occupation of the receptor.
    Rauch B; Colvin RA; Messineo FC
    J Mol Cell Cardiol; 1989 May; 21(5):495-506. PubMed ID: 2778805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A muscarinic receptor type in human lymphocytes: a comparison of 3H-QNB binding to intact lymphocytes and lysed lymphocyte membranes.
    Adem A; Nordberg A; Slanina P
    Life Sci; 1986 Apr; 38(15):1359-68. PubMed ID: 3959757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of kamikihito, a traditional Chinese medicine, on neurotransmitter receptor binding in the aged rat brain determined by in vitro autoradiography (1): Changes in the [3H]QNB binding.
    Hayashi T; Yamada K; Hasegawa T; Ishihara S; Kameyama T; Morimasa T; Kaneyuki T; Shohmori T; Nabeshima T
    Jpn J Pharmacol; 1994 Apr; 64(4):303-6. PubMed ID: 8057532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of veratridine on [3H]-L-quinuclidinyl benzilate ([3H]QNB) binding in mouse hindbrain.
    Mack JE; Matthews JC
    Biochem Pharmacol; 1987 Apr; 36(7):991-4. PubMed ID: 3566814
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potency ratio for the inhibition of 3H-QNB and 3H-cis-methyldioxolane binding predicts agonist or antagonist activity on muscarinic receptors.
    Moret C; Pastrie I; Briley M
    Methods Find Exp Clin Pharmacol; 1988 Oct; 10(10):619-21. PubMed ID: 3236936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic deficits in the septal-hippocampal pathway of the SAM-P/8 senescence accelerated mouse.
    Strong R; Reddy V; Morley JE
    Brain Res; 2003 Mar; 966(1):150-6. PubMed ID: 12646318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of electroconvulsive shock on muscarinic cholinergic receptors in rat cerebral cortex and hippocampus.
    Lerer B; Stanley M; Demetriou S; Gershon S
    J Neurochem; 1983 Dec; 41(6):1680-3. PubMed ID: 6644306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of in vivo and in vitro treatments with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on putative muscarinic receptor subtypes in rat brain.
    Norman AB; Creese I
    Mol Pharmacol; 1986 Aug; 30(2):96-103. PubMed ID: 3755499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinuclidinyl benzilate binding in house fly heads and rat brain.
    Jones SW; Sumikawa K
    J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of [3H]pirenzepine and [3H]quinuclidinylbenzilate binding to muscarinic cholinergic receptors in rat brain.
    Luthin GR; Wolfe BB
    J Pharmacol Exp Ther; 1984 Mar; 228(3):648-55. PubMed ID: 6546770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of muscarinic M1 receptors with aging in the cerebral cortex of Fisher 344 rats.
    Schwarz RD; Bernabei AA; Spencer CJ; Pugsley TA
    Pharmacol Biochem Behav; 1990 Mar; 35(3):589-93. PubMed ID: 2339151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of lithium on [3H](-)quinuclidinyl benzilate [( 3H](-)QNB) binding to rat brain muscarinic cholinergic receptors.
    Hruska RE; Ludmer LM; Pert A; Bunney WE
    J Neurosci Res; 1984; 11(2):171-7. PubMed ID: 6423831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Corticosterone modulation of neurotransmitter receptors in rat hippocampus: a quantitative autoradiographic study.
    Biegon A; Rainbow TC; McEwen BS
    Brain Res; 1985 Apr; 332(2):309-14. PubMed ID: 2986762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.